EP3307734
Kjarnaviðtakastillar (ROR) til meðferðar við bólgu- og sjálfsofnæmissjúkdómum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
8.6.2016EP published:
27.11.2019EP application number:
16731721.3
EP translation filed:
18.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
7.6.2036Expiry date:
7.6.2024
Title:
NUCLEAR RECEPTOR MODULATORS (ROR) FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
Timeline
Today
8.6.2016EP application
27.11.2019EP Publication
18.12.2019Translation submitted
15.1.2020Registration published
7.6.2024Expires
Owner
Name:
AbbVie Inc.Address:
1 North Waukegan Road, 60064, North Chicago, IL, US
Inventor
Name:
ARGIRIADI, Maria, A.Address:
Southborough, MA, US
Name:
BREINLINGER, Eric, C.Address:
Charlton, MA, US
Name:
CUSACK, Kevin, P.Address:
Holden, MA, US
Name:
HOBSON, Adrian, D.Address:
Shrewsbury, MA, US
Name:
POTIN, DominiqueAddress:
Talant, FR
Name:
BARTH, MartineAddress:
Asnières les Dijon, FR
Name:
AMAUDRUT, JérômeAddress:
Dijon, FR
Name:
POUPARDIN, OliviaAddress:
Varios et Chaignot, FR
Name:
MOUNIER, LaurentAddress:
Marsannay le Bois, FR
Name:
KORT, Michael, E.Address:
Lake Bluff, IL, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/IB2015/001693Date:
9.6.2015Country:
WO
Number:
201562257806 PDate:
20.11.2015Country:
US
Number:
201662343905 PDate:
1.6.2016Country:
US
Classification
Categories:
C07D 405/14, C07D 401/10, C07D 235/16, C07D 403/10, C07D 405/10, C07D 471/04, C07D 487/04, C07D 491/10, C07D 209/14, C07D 209/18, A61K 31/404, A61K 31/416, A61P 29/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 15.5.2020
Expires: 7.6.2021
Payer: Örn Þór slf.
Number: 6
Paid: 12.5.2021
Expires: 7.6.2022
Payer: Örn Þór slf.
Number: 7
Paid: 18.5.2022
Expires: 7.6.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.5.2023
Expires: 7.6.2024
Payer: Árnason Faktor ehf.